Search Beyond News…

MarketsandMarkets forecasts the global urinalysis market to grow to $7.16 billion by 2031, driven by an 8.0% CAGR from a 2026 baseline of $4.88 billion

Executive summary: MarketsandMarkets released a report projecting the urinalysis market to reach USD 7.16 billion by 2031, up from USD 4.88 billion in 2026, with a CAGR of 8.0%. The growth signals rising demand for diagnostic urine testing, influencing investment in lab equipment and point‑of‑care devices across healthcare providers.

Who is involved: MarketsandMarkets (research firm), healthcare diagnostics manufacturers, and end‑users such as hospitals and clinics.

Likely next: Companies may accelerate R&D on urine‑based biomarkers and diagnostic platforms to capture expanding market share; periodic updates from MarketsandMarkets are expected as new data emerge.

The report projects steady expansion of the urinalysis market, citing rising prevalence of urinary tract infections, aging populations and advances in point‑of‑care testing as key drivers. It notes the market size increase from $4.88 billion in 2026 to $7.16 billion in 2031, reflecting a modest but consistent growth trajectory. The forecast assumes continued adoption of automated analyzers and reimbursement support, without specifying particular companies or regulatory changes.

Timeline

Key entities

Sources

Related cases

Browse the full archive →